Literature DB >> 2050207

Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?

P C Rowe1, W Walop, H Lior, A M Mackenzie.   

Abstract

We conducted a 4-year retrospective cohort study to better define the risk of haemolytic anaemia and haemolytic uraemic syndrome (HUS) in children following sporadic gastrointestinal infection with the O 157.H7 serotype of Escherichia coli. Of the 72 children infected with this organism, 9 (12.5%) developed haemolytic anaemia, 6 of whom had HUS. No child in a cohort of 72 age-matched controls with Campylobacter jejuni gastroenteritis developed haemolytic anaemia (P = 0.003). Females had a significantly greater risk of developing haemolytic anaemia after E. coli O 157. H7 infection than did males (8/29 females v. 1/43 males; P = 0.003). In a logistic regression model, female gender emerged as the only statistically significant risk factor for haemolytic anaemia (odds ratio 3.85; 95% confidence interval 1.24-12). These results are consistent with recent reports of a moderate increase in the risk of HUS for females.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050207      PMCID: PMC2271874          DOI: 10.1017/s0950268800067583

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  26 in total

1.  SEX DIFFERENCES IN SUSCEPTIBILITY TO INFECTIONS.

Authors:  T C WASHBURN; D N MEDEARIS; B CHILDS
Journal:  Pediatrics       Date:  1965-01       Impact factor: 7.124

2.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

3.  Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.

Authors:  N Cimolai; J E Carter; B J Morrison; J D Anderson
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

4.  A sex difference in immunologic responsiveness.

Authors:  R M Michaels; K D Rogers
Journal:  Pediatrics       Date:  1971-01       Impact factor: 7.124

5.  Immunological bases for superior survival of females.

Authors:  D T Purtilo; J L Sullivan
Journal:  Am J Dis Child       Date:  1979-12

6.  The association of serum IgM and IgG levels with the number of X chromosomes in patients with abnormal number of X chromosomes.

Authors:  T Nurmi
Journal:  J Immunogenet       Date:  1982-06

7.  Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.

Authors:  D R Pollard; W M Johnson; H Lior; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

8.  The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome.

Authors:  D Dolislager; B Tune
Journal:  Am J Dis Child       Date:  1978-01

9.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Human X chromosome carries quantitative genes for immunoglobulin M.

Authors:  F J Grundbacher
Journal:  Science       Date:  1972-04-21       Impact factor: 47.728

View more
  8 in total

Review 1.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

2.  Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Neurological involvement in children with hemolytic uremic syndrome.

Authors:  Caoimhe Costigan; Tara Raftery; Atif Awan; Kathleen M Gorman; Anne G Carroll; Dermot Wildes; Claire Reynolds; Robert Cunney; Niamh Dolan; Richard J Drew; Bryan J Lynch; Declan J O'Rourke; Maria Stack; Clodagh Sweeney; Amre Shahwan; Eilish Twomey; Mary Waldron; Michael Riordan
Journal:  Eur J Pediatr       Date:  2021-08-10       Impact factor: 3.860

4.  Production and characterization of protective human antibodies against Shiga toxin 1.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Haemolytic anaemia in association with Escherichia coli O157 infection in two sisters.

Authors:  C M Pennings; R C Seitz; H Karch; H G Lenard
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

Review 6.  Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  BMC Public Health       Date:  2014-11-22       Impact factor: 3.295

7.  Hemolytic uremic syndrome risk and Escherichia coli O157:H7.

Authors:  Boldtsetseg Tserenpuntsag; Hwa-Gan Chang; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

8.  Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina.

Authors:  Marta Rivas; Sergio Sosa-Estani; Josefa Rangel; Maria G Caletti; Patricia Vallés; Carlos D Roldán; Laura Balbi; Maria C Marsano de Mollar; Diego Amoedo; Elizabeth Miliwebsky; Isabel Chinen; Robert M Hoekstra; Paul Mead; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.